The latest closing stock price for Unicycive Therapeutics as of September 18, 2024 is 0.39.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-933 today, roughly -1 times their original investment - a -59.36% compound annual growth rate over 3 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 1.82, which is 366.7% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 48.7% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.82.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-933 today, roughly -1 times their original investment - a -59.36% compound annual growth rate over 3 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 1.82, which is 366.7% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 48.7% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.82.